カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

蓄膿症治療のグローバル市場2023：経口、非経口

■ 英語タイトル：Global Pyomyositis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11535）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11535
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[蓄膿症治療のグローバル市場2023：経口、非経口]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、蓄膿症治療のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の蓄膿症治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 蓄膿症治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

蓄膿症治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・経口、非経口

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・Novartis AG、Merck & Co.、Mallinckrodt、Akorn、Amgen Inc、Bausch Health、Pfizer Inc.、Corbus Pharmaceuticals Holdings Inc.、IDERA、Genentech、Inc. AbbVie Inc.、GlaxoSmithKline plc.、Milo Biotechnology、CytRx Corporation、Sanofi Promega、AstraZeneca

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、蓄膿症治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な蓄膿症治療メーカーの企業概要、2019年～2022年までの蓄膿症治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な蓄膿症治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別蓄膿症治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの蓄膿症治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での蓄膿症治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および蓄膿症治療の産業チェーンを掲載しています。
・第14、15章では、蓄膿症治療の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 蓄膿症治療の概要
– 種類別分析（2018年vs2022年vs2029年）：経口、非経口
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界の蓄膿症治療市場規模・予測
– 世界の蓄膿症治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novartis AG、Merck & Co.、Mallinckrodt、Akorn、Amgen Inc、Bausch Health、Pfizer Inc.、Corbus Pharmaceuticals Holdings Inc.、IDERA、Genentech、Inc. AbbVie Inc.、GlaxoSmithKline plc.、Milo Biotechnology、CytRx Corporation、Sanofi Promega、AstraZeneca
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口、非経口
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・蓄膿症治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・蓄膿症治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・蓄膿症治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・蓄膿症治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・蓄膿症治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Pyomyositis Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pyomyositis Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Parenteral
1.4 Market Analysis by Application
1.4.1 Overview: Global Pyomyositis Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Pyomyositis Treatment Market Size & Forecast
1.5.1 Global Pyomyositis Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pyomyositis Treatment Sales Quantity (2018-2029)
1.5.3 Global Pyomyositis Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Pyomyositis Treatment Product and Services
2.1.4 Novartis AG Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Merck & Co.
2.2.1 Merck & Co. Details
2.2.2 Merck & Co. Major Business
2.2.3 Merck & Co. Pyomyositis Treatment Product and Services
2.2.4 Merck & Co. Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co. Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Pyomyositis Treatment Product and Services
2.3.4 Mallinckrodt Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Akorn
2.4.1 Akorn Details
2.4.2 Akorn Major Business
2.4.3 Akorn Pyomyositis Treatment Product and Services
2.4.4 Akorn Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Akorn Recent Developments/Updates
2.5 Amgen Inc
2.5.1 Amgen Inc Details
2.5.2 Amgen Inc Major Business
2.5.3 Amgen Inc Pyomyositis Treatment Product and Services
2.5.4 Amgen Inc Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amgen Inc Recent Developments/Updates
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Pyomyositis Treatment Product and Services
2.6.4 Bausch Health Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bausch Health Recent Developments/Updates
2.7 Pfizer Inc.
2.7.1 Pfizer Inc. Details
2.7.2 Pfizer Inc. Major Business
2.7.3 Pfizer Inc. Pyomyositis Treatment Product and Services
2.7.4 Pfizer Inc. Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Inc. Recent Developments/Updates
2.8 Corbus Pharmaceuticals Holdings Inc.
2.8.1 Corbus Pharmaceuticals Holdings Inc. Details
2.8.2 Corbus Pharmaceuticals Holdings Inc. Major Business
2.8.3 Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Product and Services
2.8.4 Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Corbus Pharmaceuticals Holdings Inc. Recent Developments/Updates
2.9 IDERA
2.9.1 IDERA Details
2.9.2 IDERA Major Business
2.9.3 IDERA Pyomyositis Treatment Product and Services
2.9.4 IDERA Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 IDERA Recent Developments/Updates
2.10 Genentech
2.10.1 Genentech Details
2.10.2 Genentech Major Business
2.10.3 Genentech Pyomyositis Treatment Product and Services
2.10.4 Genentech Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Genentech Recent Developments/Updates
2.11 Inc. AbbVie Inc.
2.11.1 Inc. AbbVie Inc. Details
2.11.2 Inc. AbbVie Inc. Major Business
2.11.3 Inc. AbbVie Inc. Pyomyositis Treatment Product and Services
2.11.4 Inc. AbbVie Inc. Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Inc. AbbVie Inc. Recent Developments/Updates
2.12 GlaxoSmithKline plc.
2.12.1 GlaxoSmithKline plc. Details
2.12.2 GlaxoSmithKline plc. Major Business
2.12.3 GlaxoSmithKline plc. Pyomyositis Treatment Product and Services
2.12.4 GlaxoSmithKline plc. Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GlaxoSmithKline plc. Recent Developments/Updates
2.13 Milo Biotechnology
2.13.1 Milo Biotechnology Details
2.13.2 Milo Biotechnology Major Business
2.13.3 Milo Biotechnology Pyomyositis Treatment Product and Services
2.13.4 Milo Biotechnology Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Milo Biotechnology Recent Developments/Updates
2.14 CytRx Corporation
2.14.1 CytRx Corporation Details
2.14.2 CytRx Corporation Major Business
2.14.3 CytRx Corporation Pyomyositis Treatment Product and Services
2.14.4 CytRx Corporation Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 CytRx Corporation Recent Developments/Updates
2.15 Sanofi Promega
2.15.1 Sanofi Promega Details
2.15.2 Sanofi Promega Major Business
2.15.3 Sanofi Promega Pyomyositis Treatment Product and Services
2.15.4 Sanofi Promega Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sanofi Promega Recent Developments/Updates
2.16 AstraZeneca
2.16.1 AstraZeneca Details
2.16.2 AstraZeneca Major Business
2.16.3 AstraZeneca Pyomyositis Treatment Product and Services
2.16.4 AstraZeneca Pyomyositis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 AstraZeneca Recent Developments/Updates
3 Competitive Environment: Pyomyositis Treatment by Manufacturer
3.1 Global Pyomyositis Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pyomyositis Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Pyomyositis Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pyomyositis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pyomyositis Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Pyomyositis Treatment Manufacturer Market Share in 2022
3.5 Pyomyositis Treatment Market: Overall Company Footprint Analysis
3.5.1 Pyomyositis Treatment Market: Region Footprint
3.5.2 Pyomyositis Treatment Market: Company Product Type Footprint
3.5.3 Pyomyositis Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pyomyositis Treatment Market Size by Region
4.1.1 Global Pyomyositis Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Pyomyositis Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Pyomyositis Treatment Average Price by Region (2018-2029)
4.2 North America Pyomyositis Treatment Consumption Value (2018-2029)
4.3 Europe Pyomyositis Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Pyomyositis Treatment Consumption Value (2018-2029)
4.5 South America Pyomyositis Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Pyomyositis Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pyomyositis Treatment Sales Quantity by Type (2018-2029)
5.2 Global Pyomyositis Treatment Consumption Value by Type (2018-2029)
5.3 Global Pyomyositis Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pyomyositis Treatment Sales Quantity by Application (2018-2029)
6.2 Global Pyomyositis Treatment Consumption Value by Application (2018-2029)
6.3 Global Pyomyositis Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Pyomyositis Treatment Sales Quantity by Type (2018-2029)
7.2 North America Pyomyositis Treatment Sales Quantity by Application (2018-2029)
7.3 North America Pyomyositis Treatment Market Size by Country
7.3.1 North America Pyomyositis Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Pyomyositis Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pyomyositis Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Pyomyositis Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Pyomyositis Treatment Market Size by Country
8.3.1 Europe Pyomyositis Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Pyomyositis Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pyomyositis Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pyomyositis Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pyomyositis Treatment Market Size by Region
9.3.1 Asia-Pacific Pyomyositis Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pyomyositis Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pyomyositis Treatment Sales Quantity by Type (2018-2029)
10.2 South America Pyomyositis Treatment Sales Quantity by Application (2018-2029)
10.3 South America Pyomyositis Treatment Market Size by Country
10.3.1 South America Pyomyositis Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Pyomyositis Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pyomyositis Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pyomyositis Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pyomyositis Treatment Market Size by Country
11.3.1 Middle East & Africa Pyomyositis Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pyomyositis Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pyomyositis Treatment Market Drivers
12.2 Pyomyositis Treatment Market Restraints
12.3 Pyomyositis Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pyomyositis Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pyomyositis Treatment
13.3 Pyomyositis Treatment Production Process
13.4 Pyomyositis Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pyomyositis Treatment Typical Distributors
14.3 Pyomyositis Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Pyomyositis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pyomyositis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Pyomyositis Treatment Product and Services
Table 6. Novartis AG Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co. Major Business
Table 10. Merck & Co. Pyomyositis Treatment Product and Services
Table 11. Merck & Co. Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck & Co. Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Pyomyositis Treatment Product and Services
Table 16. Mallinckrodt Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Akorn Basic Information, Manufacturing Base and Competitors
Table 19. Akorn Major Business
Table 20. Akorn Pyomyositis Treatment Product and Services
Table 21. Akorn Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Akorn Recent Developments/Updates
Table 23. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Inc Major Business
Table 25. Amgen Inc Pyomyositis Treatment Product and Services
Table 26. Amgen Inc Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Amgen Inc Recent Developments/Updates
Table 28. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 29. Bausch Health Major Business
Table 30. Bausch Health Pyomyositis Treatment Product and Services
Table 31. Bausch Health Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bausch Health Recent Developments/Updates
Table 33. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Inc. Major Business
Table 35. Pfizer Inc. Pyomyositis Treatment Product and Services
Table 36. Pfizer Inc. Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Inc. Recent Developments/Updates
Table 38. Corbus Pharmaceuticals Holdings Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Corbus Pharmaceuticals Holdings Inc. Major Business
Table 40. Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Product and Services
Table 41. Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Corbus Pharmaceuticals Holdings Inc. Recent Developments/Updates
Table 43. IDERA Basic Information, Manufacturing Base and Competitors
Table 44. IDERA Major Business
Table 45. IDERA Pyomyositis Treatment Product and Services
Table 46. IDERA Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. IDERA Recent Developments/Updates
Table 48. Genentech Basic Information, Manufacturing Base and Competitors
Table 49. Genentech Major Business
Table 50. Genentech Pyomyositis Treatment Product and Services
Table 51. Genentech Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Genentech Recent Developments/Updates
Table 53. Inc. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Inc. AbbVie Inc. Major Business
Table 55. Inc. AbbVie Inc. Pyomyositis Treatment Product and Services
Table 56. Inc. AbbVie Inc. Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Inc. AbbVie Inc. Recent Developments/Updates
Table 58. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 59. GlaxoSmithKline plc. Major Business
Table 60. GlaxoSmithKline plc. Pyomyositis Treatment Product and Services
Table 61. GlaxoSmithKline plc. Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. GlaxoSmithKline plc. Recent Developments/Updates
Table 63. Milo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 64. Milo Biotechnology Major Business
Table 65. Milo Biotechnology Pyomyositis Treatment Product and Services
Table 66. Milo Biotechnology Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Milo Biotechnology Recent Developments/Updates
Table 68. CytRx Corporation Basic Information, Manufacturing Base and Competitors
Table 69. CytRx Corporation Major Business
Table 70. CytRx Corporation Pyomyositis Treatment Product and Services
Table 71. CytRx Corporation Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. CytRx Corporation Recent Developments/Updates
Table 73. Sanofi Promega Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Promega Major Business
Table 75. Sanofi Promega Pyomyositis Treatment Product and Services
Table 76. Sanofi Promega Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Promega Recent Developments/Updates
Table 78. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 79. AstraZeneca Major Business
Table 80. AstraZeneca Pyomyositis Treatment Product and Services
Table 81. AstraZeneca Pyomyositis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. AstraZeneca Recent Developments/Updates
Table 83. Global Pyomyositis Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Pyomyositis Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Pyomyositis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Pyomyositis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Pyomyositis Treatment Production Site of Key Manufacturer
Table 88. Pyomyositis Treatment Market: Company Product Type Footprint
Table 89. Pyomyositis Treatment Market: Company Product Application Footprint
Table 90. Pyomyositis Treatment New Market Entrants and Barriers to Market Entry
Table 91. Pyomyositis Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Pyomyositis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Pyomyositis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Pyomyositis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Pyomyositis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Pyomyositis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Pyomyositis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Pyomyositis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Pyomyositis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Pyomyositis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Pyomyositis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Pyomyositis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Pyomyositis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Pyomyositis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Pyomyositis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Pyomyositis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Pyomyositis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Pyomyositis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Pyomyositis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Pyomyositis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Pyomyositis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Pyomyositis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Pyomyositis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Pyomyositis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Pyomyositis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Pyomyositis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Pyomyositis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Pyomyositis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Pyomyositis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Pyomyositis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Pyomyositis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Pyomyositis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Pyomyositis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Pyomyositis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Pyomyositis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Pyomyositis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Pyomyositis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Pyomyositis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Pyomyositis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Pyomyositis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Pyomyositis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Pyomyositis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Pyomyositis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Pyomyositis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Pyomyositis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Pyomyositis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Pyomyositis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Pyomyositis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Pyomyositis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Pyomyositis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Pyomyositis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Pyomyositis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Pyomyositis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Pyomyositis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Pyomyositis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Pyomyositis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Pyomyositis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Pyomyositis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Pyomyositis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Pyomyositis Treatment Raw Material
Table 151. Key Manufacturers of Pyomyositis Treatment Raw Materials
Table 152. Pyomyositis Treatment Typical Distributors
Table 153. Pyomyositis Treatment Typical Customers
List of Figures
Figure 1. Pyomyositis Treatment Picture
Figure 2. Global Pyomyositis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pyomyositis Treatment Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Parenteral Examples
Figure 6. Global Pyomyositis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pyomyositis Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Pyomyositis Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pyomyositis Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pyomyositis Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Pyomyositis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Pyomyositis Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pyomyositis Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pyomyositis Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pyomyositis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pyomyositis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pyomyositis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pyomyositis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pyomyositis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pyomyositis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pyomyositis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pyomyositis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pyomyositis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pyomyositis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pyomyositis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pyomyositis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Pyomyositis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Pyomyositis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Pyomyositis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Pyomyositis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pyomyositis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Pyomyositis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pyomyositis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pyomyositis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pyomyositis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Pyomyositis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pyomyositis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pyomyositis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pyomyositis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Pyomyositis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pyomyositis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pyomyositis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pyomyositis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Pyomyositis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pyomyositis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pyomyositis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pyomyositis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Pyomyositis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pyomyositis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pyomyositis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pyomyositis Treatment Market Drivers
Figure 74. Pyomyositis Treatment Market Restraints
Figure 75. Pyomyositis Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pyomyositis Treatment in 2022
Figure 78. Manufacturing Process Analysis of Pyomyositis Treatment
Figure 79. Pyomyositis Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source

※参考情報

蓄膿症は主に鼻腔や副鼻腔に膿がたまる病態を指し、一般的には副鼻腔炎の一種として理解されています。ここでは、蓄膿症の治療方法について詳しく説明し、その特徴、種類、用途、関連技術などを考察いたします。

蓄膿症は、通常、副鼻腔内に細菌やウイルスが感染し、炎症を引き起こすことから始まります。これにより、膿が蓄積され、鼻づまり、頭痛、顔面の圧迫感、嗅覚の低下などの症状を伴うことが多いです。特に慢性的な蓄膿症は、治療が難しくなることがあります。

治療方法は、症状の重症度や患者の状態、徴候の持続期間に応じて異なります。一般的には、薬物療法が第一選択肢とされています。抗生物質は、細菌感染が原因である場合に処方されることが多く、感染を抑える効果があります。軽度から中等度の蓄膿症では、経口あるいは局所用のコルチコステロイドを使用し、炎症を軽減することを目的とします。

また、痛みや不快感を緩和するために、鎮痛剤や解熱剤も併用されることがあります。生活習慣の見直しや加湿器の使用、蒸気吸入といった自宅療法も効果的です。特に、蒸気吸入は気道を開放し、鼻腔内の膿を排出しやすくする効果があります。

さらに、慢性蓄膿症の場合、手術治療も考慮されます。内視鏡下副鼻腔手術は、障害された副鼻腔の通気を改善し、膿を効果的に排出する手段となります。手術は、薬物療法が効果を示さない場合や、反復的な発作を引き起こす患者に提案されます。

最近では、蓄膿症の治療においては、患者の生活の質を考慮した新しいアプローチが求められています。たとえば、アレルギーが関与している場合、アレルゲンの特定と回避が重要です。また、鼻腔内のフローや細菌の状態をモニタリングするための新技術も開発されています。これにより、よりパーソナライズされた治療計画が立案されることが期待されています。

再発を防ぐためには、規則的なフォローアップが不可欠です。特に慢性蓄膿症では、症状の早期発見と対処が患者の満足度や生活の質に直結します。医療者と患者が密にコミュニケーションを取り、適切な治療法を選択することが重要です。

蓄膿症治療に関連する技術としては、鼻腔内スコープを用いた内視鏡検査が挙げられます。これにより、医師は炎症の程度や副鼻腔の状態を直接観察することができ、より正確な診断と治療が行えます。

また、最近では再生医療の観点からの治療法も研究されています。自家組織を利用した治療法や、幹細胞を用いたアプローチにより、より根本的な解決策が模索されています。これにより、蓄膿症に伴う慢性的な不快感を軽減する可能性が高まっています。

蓄膿症の治療は、病状に応じた適切なアプローチが求められます。薬物療法や手術治療に加え、患者自身の生活スタイルの改善や新しい医療技術の導入が、症状の緩和と再発防止に寄与します。今後も蓄膿症の理解を深め、新たな治療法の開発が期待されるところです。個々の患者に対して的確な治療計画を立てることが、より良い結果へとつながります。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ドライアイ治療機のグローバル市場2023：手持ち式ドライアイ治療器、卓上型ドライアイ治療器
  • 世界の鼓膜治療装置市場2023年：企業・地域・タイプ・用途別分析
  • 多汗症治療用ボトックスのグローバル市場2023：50U、100U、その他
  • 前立腺肥大症治療装置のグローバル市場2023：レーザー系装置、マイクロ波系装置、高周波系装置、その他
  • 筋骨格系腫瘍治療のグローバル市場2023：手術、化学療法
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11535 )"蓄膿症治療のグローバル市場2023：経口、非経口" (英文：Global Pyomyositis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。